An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up
|
|||||
       |
A developer of therapies addressing the body’s microbe communities is selling off key assets to another biotechnology company, after problems developed with its lead program. . . . → Read More: Collapsed Microbiome Biotech Sells Off Assets  Comments are closed  Intellectual property, New products  biomedical, biotechnology, cancer, clinical trials, engineering, entrepreneurs, licensing, life sciences, manufacturing, mathematics, pharmaceuticals, university 
A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
Research with lab mice shows an experimental vaccine stimulates the body’s basic immune system to protect against a range of pathogens associated with hospital infections. . . . → Read More: Vaccine Shown to Protect Against Multiple Hospital Pathogens Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, grant, health care, licensing, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks. . . . → Read More: Cardiac Tech Start-Up Partners with Mayo Clinic 
A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains. . . . → Read More: FDA Clears Biotech Seasonal Flu Treatment Trial Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, licensing, life sciences, pharmaceuticals 
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies 
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company 
A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology 
A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts